Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

被引：0

作者：

David F. McDermott

Mahrukh A. Huseni

Michael B. Atkins

Robert J. Motzer

Brian I. Rini

Bernard Escudier

Lawrence Fong

Richard W. Joseph

Sumanta K. Pal

James A. Reeves

Mario Sznol

John Hainsworth

W. Kimryn Rathmell

Walter M. Stadler

Thomas Hutson

Martin E. Gore

Alain Ravaud

Sergio Bracarda

Cristina Suárez

Riccardo Danielli

Viktor Gruenwald

Toni K. Choueiri

Dorothee Nickles

Suchit Jhunjhunwala

Elisabeth Piault-Louis

Alpa Thobhani

Jiaheng Qiu

Daniel S. Chen

Priti S. Hegde

Christina Schiff

Gregg D. Fine

Thomas Powles

机构：

[1] Beth Israel Deaconess Medical Center,

[2] Genentech,undefined

[3] Inc.,undefined

[4] Georgetown Lombardi Comprehensive Cancer Center,undefined

[5] Memorial Sloan Kettering Cancer Center,undefined

[6] Cleveland Clinic Taussig Cancer Institute,undefined

[7] Gustave Roussy,undefined

[8] University of California,undefined

[9] San Francisco School of Medicine,undefined

[10] Mayo Clinic Hospital –Florida,undefined

[11] City of Hope Comprehensive Cancer Center,undefined

[12] Florida Cancer Specialists,undefined

[13] Yale School of Medicine,undefined

[14] Sarah Cannon Research Institute,undefined

[15] Vanderbilt University Medical Center,undefined

[16] University of Chicago Medicine,undefined

[17] Texas Oncology – Baylor Charles A. Sammons Cancer Center,undefined

[18] Royal Marsden Hospital,undefined

[19] CHU Hopitaux de Bordeaux – Hôpital Saint-André,undefined

[20] Ospedale San Donato,undefined

[21] Azienda USL Toscana Sudest,undefined

[22] Vall d’Hebron Institute of Oncology,undefined

[23] Vall d’Hebron University Hospital,undefined

[24] Universitat Autònoma de Barcelona,undefined

[25] Azienda Ospedaliera Universitaria Senese,undefined

[26] Center for Immune-Oncology,undefined

[27] Medizinische Hochschule,undefined

[28] Zentrum Innere Medizin,undefined

[29] Abt. Hämatologie u. Onkologie,undefined

[30] Dana-Farber Cancer Institute,undefined

[31] Roche Products Ltd,undefined

[32] Barts Cancer Institute and the Royal Free Hospital,undefined

[33] Queen Mary University of London,undefined

来源：

Nature Medicine | 2018年 / 24卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

In the version of this article originally published, there was an error in Fig. 2n. The top line of the HR comparison chart originally was Atezo + bev vs sun. It should have been Atezo + bev vs atezo. The error has been corrected in the HTML and PDF versions of this article.

引用

下载

页码：1941 / 1941

共 50 条

[1] Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
McDermott, David F.
Huseni, Mahrukh A.
Atkins, Michael B.
Motzer, Robert J.
Rini, Brian I.
Escudier, Bernard
Fong, Lawrence
Joseph, Richard W.
Pal, Sumanta K.
Reeves, James A.
Sznol, Mario
Hainsworth, John
Rathmell, W. Kimryn
Stadler, Walter M.
Hutson, Thomas
Gore, Martin E.
Ravaud, Alain
Bracarda, Sergio
Suarez, Cristina
Danielli, Riccardo
Gruenwald, Viktor
Choueiri, Toni K.
Nickles, Dorothee
Jhunjhunwala, Suchit
Piault-Louis, Elisabeth
Thobhani, Alpa
Qiu, Jiaheng
Chen, Daniel S.
Hegde, Priti S.
Schiff, Christina
Fine, Gregg D.
Powles, Thomas
NATURE MEDICINE, 2018, 24 (06) : 749 - +
[2] Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F. McDermott
Mahrukh A. Huseni
Michael B. Atkins
Robert J. Motzer
Brian I. Rini
Bernard Escudier
Lawrence Fong
Richard W. Joseph
Sumanta K. Pal
James A. Reeves
Mario Sznol
John Hainsworth
W. Kimryn Rathmell
Walter M. Stadler
Thomas Hutson
Martin E. Gore
Alain Ravaud
Sergio Bracarda
Cristina Suárez
Riccardo Danielli
Viktor Gruenwald
Toni K. Choueiri
Dorothee Nickles
Suchit Jhunjhunwala
Elisabeth Piault-Louis
Alpa Thobhani
Jiaheng Qiu
Daniel S. Chen
Priti S. Hegde
Christina Schiff
Gregg D. Fine
Thomas Powles
Nature Medicine, 2018, 24 : 749 - 757
[3] Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma (vol 24, pg 749, 2018)
McDermott, David F.
Huseni, Mahrukh A.
Atkins, Michael B.
Motzer, Robert J.
Rini, Brian I.
Escudier, Bernard
Fong, Lawrence
Joseph, Richard W.
Pal, Sumanta K.
Reeves, James A.
Sznol, Mario
Hainsworth, John
Rathmell, W. Kimryn
Stadler, Walter M.
Hutson, Thomas
Gore, Martin E.
Ravaud, Alain
Bracarda, Sergio
Suarez, Cristina
Danielli, Riccardo
Gruenwald, Viktor
Choueiri, Toni K.
Nickles, Dorothee
Jhunjhunwala, Suchit
Piault-Louis, Elisabeth
Thobhani, Alpa
Qiu, Jiaheng
Chen, Daniel S.
Hegde, Priti S.
Schiff, Christina
Fine, Gregg D.
Powles, Thomas
NATURE MEDICINE, 2018, 24 (12) : 1941 - 1941
[4] Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Zhu, Andrew X.
Abbas, Alexander R.
de Galarreta, Marina Ruiz
Guan, Yinghui
Lu, Shan
Koeppen, Hartmut
Zhang, Wenjun
Hsu, Chih-Hung
He, Aiwu Ruth
Ryoo, Baek-Yeol
Yau, Thomas
Kaseb, Ahmed O.
Burgoyne, Adam M.
Dayyani, Farshid
Spahn, Jessica
Verret, Wendy
Finn, Richard S.
Toh, Han Chong
Lujambio, Amaia
Wang, Yulei
NATURE MEDICINE, 2022, 28 (08) : 1599 - +
[5] Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Andrew X. Zhu
Alexander R. Abbas
Marina Ruiz de Galarreta
Yinghui Guan
Shan Lu
Hartmut Koeppen
Wenjun Zhang
Chih-Hung Hsu
Aiwu Ruth He
Baek-Yeol Ryoo
Thomas Yau
Ahmed O. Kaseb
Adam M. Burgoyne
Farshid Dayyani
Jessica Spahn
Wendy Verret
Richard S. Finn
Han Chong Toh
Amaia Lujambio
Yulei Wang
Nature Medicine, 2022, 28 : 1599 - 1611
[6] Salvage Therapy with Bevacizumab-Sunitinib Combination after Failure of Sunitinib Alone for Metastatic Renal Cell Carcinoma: A Case Series
Medioni, Jacques
Banu, Eugeniu
Helley, Dominique
Scotte, Florian
Fournier, Laure
Mejean, Arnaud
Chedid, Antoine
Azizi, Michel
Andrieu, Jean-Marie
Oudard, Stephane
EUROPEAN UROLOGY, 2009, 56 (01) : 207 - 211
[7] Metastatic Renal Cell Carcinoma: Nephrectomy plus Sunitinib versus Sunitinib Alone
Kroeger, Nils
Bedke, Jens
Burchardt, Martin
AKTUELLE UROLOGIE, 2019, 50 (02) : 132 - 134
[8] Axitinib combination therapies versus sunitinib for renal cell carcinoma
Stirrups, Robert
LANCET ONCOLOGY, 2019, 20 (03): : E141 - E141
[9] Molecular correlates of clinical response to combination immunotherapy in advanced fumarate hydratase deficient renal cell carcinoma
Xu, Y.
Xue, W.
Zhang, J.
Huang, Y.
EUROPEAN UROLOGY, 2024, 85 : S1067 - S1067
[10] Advanced Renal Cell Carcinoma: Combination of Nivolumab and Ipilimumab versus Sunitinib
Lorenz, Judith
AKTUELLE UROLOGIE, 2019, 50 (02) : 136 - 136

← 1 2 3 4 5 →